vac-3s
Vaccineexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2012 (NCT01549119)
Timeline
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vac-3s
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02390466 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2015 | InnaVirVax |
| NCT02041247 | Phase 2 | Jan 1, 2014 | InnaVirVax |
| NCT01549119 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2012 | InnaVirVax |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| InnaVirVax | For profit | 3 | 3 | 1 | 2012 |
1 organizations
Page 1 / 1